145 related articles for article (PubMed ID: 14752193)
1. Screening-detected breast cancer in a man with BRCA2 mutation: case report.
Brenner RJ; Weitzel JN; Hansen N; Boasberg P
Radiology; 2004 Feb; 230(2):553-5. PubMed ID: 14752193
[TBL] [Abstract][Full Text] [Related]
2. Case 7-2020: A 52-Year-Old Man with a Mass in the Left Breast.
Isakoff SJ; Lehman CD; Shannon KM; Basnet KM
N Engl J Med; 2020 Feb; 382(9):856-864. PubMed ID: 32101669
[No Abstract] [Full Text] [Related]
3. [Does obesity modify recurrence-free interval in breast cancer?].
Kurz C; Obermair A; Schemper W; Kubista E; Sevelda P
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():305-7. PubMed ID: 8118326
[No Abstract] [Full Text] [Related]
4. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
5. Male HER-2 positive metastatic breast cancer: A case report.
Lin N; Xu Q; Wang B; Dang Y; Lin C
Asian J Surg; 2020 Dec; 43(12):1175-1176. PubMed ID: 33077323
[No Abstract] [Full Text] [Related]
6. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
[TBL] [Abstract][Full Text] [Related]
7. Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer.
Climent J; Martinez-Climent JA; Blesa D; Garcia-Barchino MJ; Saez R; Sánchez-Izquierdo D; Azagra P; Lluch A; Garcia-Conde J
Clin Cancer Res; 2002 Dec; 8(12):3863-9. PubMed ID: 12473601
[TBL] [Abstract][Full Text] [Related]
8. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28-2003. A 51-year-old premenopausal woman with newly diagnosed breast cancer and a strong family history of breast cancer.
Ryan PD; Haber DA; Shannon KM; Smith BL; Fan MJ
N Engl J Med; 2003 Sep; 349(11):1076-82. PubMed ID: 12968092
[No Abstract] [Full Text] [Related]
9. PML protein expression in hereditary and sporadic breast cancer.
Plevová P; Bouchal J; Fiurásková M; Foretová L; Navrátilová M; Zapletalová J; Curík R; Kubala O; Prokop J; Kolár Z
Neoplasma; 2007; 54(4):263-8. PubMed ID: 17822314
[TBL] [Abstract][Full Text] [Related]
10. Rare coexistence of invasive papillary carcinoma with infiltrating ductal carcinoma in male breast: report of a case.
Bhatia A; Uma Nahar Saikia ; Kumar Y
Int J Surg Pathol; 2008 Jul; 16(3):311-3. PubMed ID: 18573787
[TBL] [Abstract][Full Text] [Related]
11. Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.
Michieletto S; Saibene T; Evangelista L; Barbazza F; Grigoletto R; Rossi G; Ghiotto C; Bozza F
Breast; 2014 Feb; 23(1):19-25. PubMed ID: 24189101
[TBL] [Abstract][Full Text] [Related]
12. BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.
Ottini L; Rizzolo P; Zanna I; Falchetti M; Masala G; Ceccarelli K; Vezzosi V; Gulino A; Giannini G; Bianchi S; Sera F; Palli D
Breast Cancer Res Treat; 2009 Aug; 116(3):577-86. PubMed ID: 18819001
[TBL] [Abstract][Full Text] [Related]
13. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys.
Cutuli B; Dalenc F; Cottu PH; Gligorov J; Guastalla JP; Petit T; Amrate A
Cancer Radiother; 2015 Aug; 19(5):295-302. PubMed ID: 26188735
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
Tas F
Onkologie; 2012; 35(3):95-8. PubMed ID: 22414972
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Male Hereditary Breast Cancer Involving a Sentinel Lymph Node Biopsy].
Tokunou K; Yamamoto T; Yamamoto H; Kamei R; Kitamura Y; Ando S
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2026-2028. PubMed ID: 28133210
[TBL] [Abstract][Full Text] [Related]
16. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
Kwiatkowska E; Teresiak M; Filas V; Karczewska A; Breborowicz D; Mackiewicz A
Clin Cancer Res; 2003 Oct; 9(12):4452-9. PubMed ID: 14555518
[TBL] [Abstract][Full Text] [Related]
17. [Synchronous sigmoid colon and breast cancers in man].
Abboud B; Nassif J; Jaoude JB; Chahine G
Gastroenterol Clin Biol; 2008 Mar; 32(3):255-7. PubMed ID: 18353581
[TBL] [Abstract][Full Text] [Related]
18. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
Kuo SH; Chen CL; Huang CS; Cheng AL
Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
[TBL] [Abstract][Full Text] [Related]
19. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
20. Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report.
Zagouri F; Sergentanis TN; Koulocheri D; Nonni A; Bousiotou A; Domeyer P; Michalopoulos NV; Dardamanis D; Konstadoulakis MM; Zografos GC
World J Surg Oncol; 2007 Sep; 5():101. PubMed ID: 17848197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
